Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Vasomotor Symptoms”

30 trials

Showing 20 of 30 results

Testing effectiveness (Phase 2)Looking for participantsNCT07042516
What this trial is testing

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

Who this might be right for
Vasomotor Symptoms
Tioga Pharmaceuticals 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06440967
What this trial is testing

Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 984
Testing effectiveness (Phase 2)Study completedNCT02100540
What this trial is testing

Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women

Who this might be right for
PMSHot Flashes
Yung Shin Pharm. Ind. Co., Ltd. 58
Testing effectiveness (Phase 2)Looking for participantsNCT06972875
What this trial is testing

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

Who this might be right for
Prostate CAAndrogen Deprivation Therapy
University of Vermont 32
Testing effectiveness (Phase 2)Ended earlyNCT02653417
What this trial is testing

Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsHot Flashes
Radius Pharmaceuticals, Inc. 139
Large-scale testing (Phase 3)Study completedNCT04209543
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,570
Testing effectiveness (Phase 2)Study completedNCT00604825
What this trial is testing

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Who this might be right for
Menopausal and Female Climacteric States
GlaxoSmithKline 356
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Testing effectiveness (Phase 2)Study completedNCT06726850
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.

Who this might be right for
Vasomotor Syndrome
Changchun GeneScience Pharmaceutical Co., Ltd. 129
Testing effectiveness (Phase 2)Ended earlyNCT06161792
What this trial is testing

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer

Who this might be right for
Hot FlashesBreast Cancer
Yung Shin Pharm. Ind. Co., Ltd. 10
Large-scale testing (Phase 3)Study completedNCT00727129
What this trial is testing

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Who this might be right for
Postmenopausal Symptoms
Upsher-Smith Laboratories 495
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Testing effectiveness (Phase 2)Ended earlyNCT04278872
What this trial is testing

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
Hot Flashes
Sojournix, Inc. 13
Large-scale testing (Phase 3)Study completedNCT04234204
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 302
Large-scale testing (Phase 3)Study completedNCT00560833
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Who this might be right for
MenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 943
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Post-approval studies (Phase 4)Study completedNCT02195609
What this trial is testing

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
MenopauseHot Flashes
Instituto Palacios 75
Testing effectiveness (Phase 2)Study completedNCT05312567
What this trial is testing

FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsMenopause
Fervent Pharmaceuticals 105
Large-scale testing (Phase 3)Study completedNCT00446199
What this trial is testing

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsHot Flashes
Bayer 735
Testing effectiveness (Phase 2)Study completedNCT06812754
What this trial is testing

Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation